Company / Inventory
Travere Therapeutics, Inc. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$36.2M
FY2025
5-year range
$4.5M / $41.9M
FY2021-FY2025
Trend
-13.6%
vs FY2024
Sector context
#65 of 105
Health Care
What the data says
At $36M, Travere Therapeutics, Inc.'s inventory ranks #65 of 105 in the Health Care sector. Inventory has fluctuated over the past 10 years, ranging from $3M in FY2016 to $42M in FY2024.
Based on SEC 10-K filings.
$36M in FY2025 with a 5-year CAGR of +36.6%.
Improved from $9M to $36M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +99.9%
- 5-Year CAGR
- +36.6%
- 10-Year CAGR
- -
Sector benchmark
#65 of 105 in Health CareTop 62% of 105This company $36.2M Sector average $885.3M
▼
-95.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +36.6%, indicating consistent growth.
- In FY2025, inventory decreased 13.6% year-over-year.
- Ranks #65 out of 105 companies in the Health Care sector.
- Peak inventory was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $36.2M | -13.6% |
| FY2024 | $41.9M | +344.8% |
| FY2023 | $9.4M | +108.0% |
| FY2022 | $4.5M | -38.2% |
| FY2021 | $7.3M | -3.9% |
| FY2020 | $7.6M | +25.1% |
| FY2019 | $6.1M | +8.2% |
| FY2018 | $5.6M | +5.0% |
| FY2017 | $5.4M | +89.3% |
| FY2016 | $2.8M | +11.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026